Di Marco T - Search Results

1

Senescent Thyrocytes, Similarly to Thyroid Tumor Cells, Elicit M2-like Macrophage Polarization In Vivo.

Mazzoni M, Mauro G, Minoli L, Cleris L, Anania MC, Di Marco T, Minna E, Pagliardini S, Rizzetti MG, Manenti G, Borrello MG, Scanziani E, Greco A. Mazzoni M, et al. Among authors: di marco t. Biology (Basel). 2021 Sep 30;10(10):985. doi: 10.3390/biology10100985. Biology (Basel). 2021. PMID: 34681084 Free PMC article.

2

Targeting COPZ1 non-oncogene addiction counteracts the viability of thyroid tumor cells.

Anania MC, Cetti E, Lecis D, Todoerti K, Gulino A, Mauro G, Di Marco T, Cleris L, Pagliardini S, Manenti G, Belmonte B, Tripodo C, Neri A, Greco A. Anania MC, et al. Among authors: di marco t. Cancer Lett. 2017 Dec 1;410:201-211. doi: 10.1016/j.canlet.2017.09.024. Epub 2017 Sep 23. Cancer Lett. 2017. PMID: 28951131

3

Mitosis perturbation by MASTL depletion impairs the viability of thyroid tumor cells.

Cetti E, Di Marco T, Mauro G, Mazzoni M, Lecis D, Minna E, Gioiosa L, Brich S, Pagliardini S, Borrello MG, Pruneri G, Anania MC, Greco A. Cetti E, et al. Among authors: di marco t. Cancer Lett. 2019 Feb 1;442:362-372. doi: 10.1016/j.canlet.2018.11.010. Epub 2018 Nov 14. Cancer Lett. 2019. PMID: 30445205

4

Targeting Non-Oncogene Addiction: Focus on Thyroid Cancer.

Anania MC, Di Marco T, Mazzoni M, Greco A. Anania MC, et al. Among authors: di marco t. Cancers (Basel). 2020 Jan 4;12(1):129. doi: 10.3390/cancers12010129. Cancers (Basel). 2020. PMID: 31947935 Free PMC article. Review.

5

COPZ1 depletion in thyroid tumor cells triggers type I IFN response and immunogenic cell death.

Di Marco T, Bianchi F, Sfondrini L, Todoerti K, Bongarzone I, Maffioli EM, Tedeschi G, Mazzoni M, Pagliardini S, Pellegrini S, Neri A, Anania MC, Greco A. Di Marco T, et al. Cancer Lett. 2020 Apr 28;476:106-119. doi: 10.1016/j.canlet.2020.02.011. Epub 2020 Feb 14. Cancer Lett. 2020. PMID: 32061953 Free article.

6

Transcriptomic landscape of TIMP3 oncosuppressor activity in thyroid carcinoma.

Mazzoni M, Todoerti K, Agnelli L, Minna E, Pagliardini S, Di Marco T, Borrello MG, Neri A, Greco A. Mazzoni M, et al. Among authors: di marco t. Cancer Cell Int. 2022 Dec 12;22(1):400. doi: 10.1186/s12935-022-02811-8. Cancer Cell Int. 2022. PMID: 36503426 Free PMC article.

7

Effectiveness of cascade filtration plasmapheresis in two patients affected by familial hypercholesterolemia.

Barbagallo CM, Averna MR, DiMarco T, Spano L, Scafidi V, Marino G, Camemi AR, Notarbartolo A. Barbagallo CM, et al. J Clin Apher. 1995;10(2):96-100. doi: 10.1002/jca.2920100209. J Clin Apher. 1995. PMID: 7592525

8

Non-oncogene dependencies: Novel opportunities for cancer therapy.

Di Marco T, Mazzoni M, Greco A, Cassinelli G. Di Marco T, et al. Biochem Pharmacol. 2024 May 2:116254. doi: 10.1016/j.bcp.2024.116254. Online ahead of print. Biochem Pharmacol. 2024. PMID: 38704100 Review.

9

Effect of daridorexant on sleep architecture in patients with chronic insomnia disorder - A pooled post hoc analysis of two randomized Phase 3 clinical studies.

Di Marco T, Djonlagic I, Dauvilliers Y, Sadeghi K, Little D, Datta AN, Hubbard J, Hajak G, Krystal A, Olivieri A, Parrino L, Puryear CB, Zammit G, Donoghue J, Scammell TE. Di Marco T, et al. Sleep. 2024 Apr 22:zsae098. doi: 10.1093/sleep/zsae098. Online ahead of print. Sleep. 2024. PMID: 38644625

10

Number, Duration, and Distribution of Wake Bouts in Patients with Insomnia Disorder: Effect of Daridorexant and Zolpidem.

Di Marco T, Scammell TE, Meinel M, Seboek Kinter D, Datta AN, Zammit G, Dauvilliers Y. Di Marco T, et al. CNS Drugs. 2023 Jul;37(7):639-653. doi: 10.1007/s40263-023-01020-9. Epub 2023 Jul 21. CNS Drugs. 2023. PMID: 37477771 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

23 results

Search Page